1. Home
  2. PTCT vs RNST Comparison

PTCT vs RNST Comparison

Compare PTCT & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • RNST
  • Stock Information
  • Founded
  • PTCT 1998
  • RNST 1904
  • Country
  • PTCT United States
  • RNST United States
  • Employees
  • PTCT N/A
  • RNST N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • PTCT Health Care
  • RNST Finance
  • Exchange
  • PTCT Nasdaq
  • RNST Nasdaq
  • Market Cap
  • PTCT 3.9B
  • RNST 3.3B
  • IPO Year
  • PTCT 2013
  • RNST N/A
  • Fundamental
  • Price
  • PTCT $50.73
  • RNST $37.26
  • Analyst Decision
  • PTCT Buy
  • RNST Buy
  • Analyst Count
  • PTCT 14
  • RNST 6
  • Target Price
  • PTCT $67.64
  • RNST $42.20
  • AVG Volume (30 Days)
  • PTCT 1.0M
  • RNST 559.6K
  • Earning Date
  • PTCT 08-07-2025
  • RNST 07-22-2025
  • Dividend Yield
  • PTCT N/A
  • RNST 2.37%
  • EPS Growth
  • PTCT N/A
  • RNST N/A
  • EPS
  • PTCT 7.51
  • RNST 2.24
  • Revenue
  • PTCT $1,772,758,000.00
  • RNST $735,631,000.00
  • Revenue This Year
  • PTCT $120.38
  • RNST $40.84
  • Revenue Next Year
  • PTCT N/A
  • RNST $13.45
  • P/E Ratio
  • PTCT $6.60
  • RNST $16.60
  • Revenue Growth
  • PTCT 91.12
  • RNST 17.24
  • 52 Week Low
  • PTCT $29.02
  • RNST $26.97
  • 52 Week High
  • PTCT $58.38
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 54.87
  • RNST 50.27
  • Support Level
  • PTCT $44.15
  • RNST $35.79
  • Resistance Level
  • PTCT $47.61
  • RNST $39.41
  • Average True Range (ATR)
  • PTCT 1.74
  • RNST 0.88
  • MACD
  • PTCT -0.12
  • RNST -0.26
  • Stochastic Oscillator
  • PTCT 81.20
  • RNST 40.06

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: